[Rupture immune tolerance by some cytostatic agents used in anticancer chemotherapy].
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004912:Erythrocytes / Q000276:immunology; D007108:Immune Tolerance / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D002955:Leucovorin / Q000008:administration & dosage; D015122:Mercaptopurine / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage*; D051381:Rats; D012756:Sheep
D000906:Antibodies; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002955:Leucovorin; D008727:Methotrexate
Rupture de la tolérance immunitaire par certains cytostatiques utilisés en chimiothérapie anticancéreuse.